Event: ASGCT 2021

0:05:26

Adaptimmune ASGCT 2021

0:01:27

Completing Your Profile and Networking at #ASGCT21

0:01:34

Entering the #ASGCT21 Exhibit Hall and Playing The Passport Game

0:04:07

What's it Like to Attend the ASGCT Annual Meeting?

0:36:54

Lunch & Learn: Annual Meeting Research Highlights

0:01:09

Attending #ASGCT21 and Building Your Schedule

0:01:58

Highlights from ASGCT 2021: iPSCs & the immunological barrier

0:02:16

HSC gene editing highlights from ASGCT 2021

0:53:05

2013 ASGCT Media Event

0:04:09

Adenovirus-Based Vaccine for COVID-19

0:38:35

Ethics: from Clinical Trials to Products - Jonathan Kimmelman

1:03:26

Lunch & Learn: Gene Therapy for SMA

0:32:31

IRB and Patient Safety - 5 Things You Must Know to Start a Human Gene Therapy Trial

0:13:59

FDA's Programs to Promote Patient Access to Investigational Therapies

1:02:21

Lunch & Learn: Intro to Viral Vectors

6:52:56

AAV Integration Roundtable

0:27:43

Overview of Standards Setting for Cell/Gene Therapies-- Case Studies

0:29:45

Phase IIb Multiple Dose, Non-Viral, Cystic Fibrosis Gene Transfer Clinical Trial

0:03:58

Complement inhibition for the treatment of TA-TMA

0:03:52

AVR-RD-01: ex vivo lentiviral gene therapy for Fabry disease

0:31:32

Oncolytic Vectors: Understanding their Potential to Treat Cancer

0:45:38

Seeing the Light with Retinal Gene Therapy: From Fantasy to Reality - Jean Bennett

0:03:02

IL-1Ra gene therapy for knee OA: interim Phase I results

1:22:54

Around the World: Advancing Gene + Cell Therapies in China